Published in Toxicol Appl Pharmacol on December 21, 2011
Low-solubility particles and a Trojan-horse type mechanism of toxicity: the case of cobalt oxide on human lung cells. Part Fibre Toxicol (2014) 0.90
p53 activation by Ni(II) is a HIF-1α independent response causing caspases 9/3-mediated apoptosis in human lung cells. Toxicol Appl Pharmacol (2013) 0.89
Heparin and carboxymethylchitosan metal nanoparticles: an evaluation of their cytotoxicity. Biomed Res Int (2013) 0.83
Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of histone demethylases using X-ray absorption spectroscopy. Biochemistry (2013) 0.78
Nickel Release, ROS Generation and Toxicity of Ni and NiO Micro- and Nanoparticles. PLoS One (2016) 0.77
10th NTES Conference: Nickel and arsenic compounds alter the epigenome of peripheral blood mononuclear cells. J Trace Elem Med Biol (2014) 0.77
Uptake, p53 pathway activation, and cytotoxic responses for Co(II) and Ni(II) in human lung cells: implications for carcinogenicity. Toxicol Sci (2013) 0.77
Research Advances on Pathways of Nickel-Induced Apoptosis. Int J Mol Sci (2015) 0.77
Plasma Anti-Glycan Antibody Profiles Associated with Nickel level in Urine. J Proteomics Bioinform (2013) 0.76
Biological and environmental interactions of emerging two-dimensional nanomaterials. Chem Soc Rev (2016) 0.76
Nickel-Refining Fumes Induced DNA Damage and Apoptosis of NIH/3T3 Cells via Oxidative Stress. Int J Environ Res Public Health (2016) 0.75
Can commonly measurable traits explain differences in metal accumulation and toxicity in earthworm species? Ecotoxicology (2013) 0.75
Toxic potential of materials at the nanolevel. Science (2006) 19.24
Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater (2009) 11.95
Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov (2010) 7.48
DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet (2000) 6.57
Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol (2011) 6.32
Harnessing actin dynamics for clathrin-mediated endocytosis. Nat Rev Mol Cell Biol (2006) 5.59
Phagocytosis of microbes: complexity in action. Annu Rev Immunol (2001) 5.49
Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett (2007) 5.48
Clathrin-coated vesicles: isolation, dissociation and factor-dependent reassociation of clathrin baskets. Cell (1979) 4.81
Virus entry by macropinocytosis. Nat Cell Biol (2009) 3.87
Cardiovascular effects of nickel in ambient air. Environ Health Perspect (2006) 3.69
Phagocytosis and the actin cytoskeleton. J Cell Sci (2001) 3.52
Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol (2008) 3.09
Cancers of the lung and nasal sinuses in nickel workers. Br J Cancer (1970) 2.67
Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol (2007) 2.59
Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol Sci (2006) 2.57
Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol Sci (2006) 2.34
Size-dependent toxicity of metal oxide particles--a comparison between nano- and micrometer size. Toxicol Lett (2009) 2.34
The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med (2007) 2.29
Regulation of macropinocytosis by p21-activated kinase-1. Mol Biol Cell (2000) 2.16
Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol (1995) 2.14
Cancers of the lung and nasal sinuses in nickel workers: a reassessment of the period of risk. Br J Ind Med (1977) 2.09
Effects of particle composition and species on toxicity of metallic nanomaterials in aquatic organisms. Environ Toxicol Chem (2008) 2.02
Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small (2011) 2.00
Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics (2009) 1.96
Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol Cell Biol (2006) 1.77
Nickel essentiality, toxicity, and carcinogenicity. Crit Rev Oncol Hematol (2002) 1.77
Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci (2000) 1.74
Interaction of nanoparticles with cells. Biomacromolecules (2009) 1.73
A review of the carcinogenicities of nickel, chromium and arsenic compounds in man and animals. Prev Med (1976) 1.73
Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano (2011) 1.66
Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J Cell Sci (2006) 1.64
Surface charge and hemolytic activity of asbestos. Environ Res (1977) 1.62
Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano (2011) 1.38
Debunking some misconceptions about nanotoxicology. Nano Lett (2010) 1.36
Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science (1991) 1.35
Carcinogenicity assessment of selected nickel compounds. Toxicol Appl Pharmacol (1997) 1.34
CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin Immunol (2000) 1.32
Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis (2006) 1.32
Occupational toxicology of nickel and nickel compounds. J Environ Pathol Toxicol Oncol (2009) 1.27
Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med (2002) 1.25
Interaction of asbestos with alveolar cells. Environ Health Perspect (1974) 1.24
Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomedicine (2010) 1.24
Pulmonary response after exposure to inhaled nickel hydroxide nanoparticles: short and long-term studies in mice. Nanotoxicology (2010) 1.20
Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers. J Biol Chem (2009) 1.17
Soluble nickel inhibits HIF-prolyl-hydroxylases creating persistent hypoxic signaling in A549 cells. Mol Carcinog (2006) 1.17
Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res (1979) 1.16
Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology (2005) 1.16
Nickel-induced histone hypoacetylation: the role of reactive oxygen species. Toxicol Sci (2003) 1.14
Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. ACS Nano (2010) 1.13
Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res (1995) 1.12
Soluble nickel interferes with cellular iron homeostasis. Mol Cell Biochem (2005) 1.11
In vitro cellular uptake and cytotoxic effect of functionalized nickel nanoparticles on leukemia cancer cells. J Nanosci Nanotechnol (2008) 1.11
Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture. Cancer Res (1981) 1.10
Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines at the xanthine-guanine phosphoribosyl transferase locus. Mutat Res (1993) 1.10
Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake. Science (1980) 1.09
Carcinogenic effects of metals. Fed Proc (1978) 1.08
Nickel decreases cellular iron level and converts cytosolic aconitase to iron-regulatory protein 1 in A549 cells. Toxicol Appl Pharmacol (2004) 1.07
Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers. Occup Environ Med (1996) 1.06
Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res (2000) 1.06
Epigenetic mechanisms in human disease. Cancer Res (2002) 1.05
Assessment of the uptake and mutagenicity of nickel chloride in salmonella tester strains. Mutat Res (1986) 1.04
Iron- and 2-oxoglutarate-dependent dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicity. Biometals (2008) 1.04
Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish. Environ Sci Technol (2009) 1.03
The role of calcium signaling in phagocytosis. J Leukoc Biol (2010) 1.03
Physiological effects of nanoparticles on fish: a comparison of nanometals versus metal ions. Environ Int (2011) 1.02
Endocytosis of beta1 integrins is an early event in migration promoted by the cell adhesion molecule L1. Exp Cell Res (2005) 1.02
Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ Mol Mutagen (1989) 1.01
Ni(II) specifically cleaves the C-terminal tail of the major variant of histone H2A and forms an oxidative damage-mediating complex with the cleaved-off octapeptide. Chem Res Toxicol (2000) 0.95
Carcinogenicity of nickel(II)hydroxides and nickel(II)sulfate in Wistar rats and its relation to the in vitro dissolution rates. Carcinogenesis (1983) 0.95
Comparisons of carcinogenicities of nickel compounds in rats. Res Commun Chem Pathol Pharmacol (1976) 0.95
Enhancement of hydroxylation and deglycosylation of 2'-deoxyguanosine by carcinogenic nickel compounds. Cancer Res (1989) 0.95
Pulmonary and systemic toxicity following exposure to nickel nanoparticles. Am J Ind Med (2010) 0.94
Nickel content of food and estimation of dietary intake. Z Lebensm Unters Forsch (1984) 0.93
Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems. Toxicol Appl Pharmacol (1981) 0.92
Ultrafine NiO particles induce cytotoxicity in vitro by cellular uptake and subsequent Ni(II) release. Chem Res Toxicol (2009) 0.92
Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells. Cancer Res (1982) 0.91
The nickel ion bioavailability model of the carcinogenic potential of nickel-containing substances in the lung. Crit Rev Toxicol (2010) 0.89
Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel(II). Chem Res Toxicol (2005) 0.89
Genotoxic activity of nickel subsulphide alpha-Ni3S2. Mutagenesis (1990) 0.88
Activation of Akt/GSK3β and Akt/Bcl-2 signaling pathways in nickel-transformed BEAS-2B cells. Int J Oncol (2011) 0.88
Carcinogenicity assessment of water-soluble nickel compounds. Crit Rev Toxicol (2009) 0.87
Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds. Mutat Res (1993) 0.87
Effect of basic compounds on the polymerization of clathrin. Biochemistry (1981) 0.86
Epigenetic mechanisms in metal toxicity. Toxicol Mech Methods (2011) 0.85
Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values. Regul Toxicol Pharmacol (2010) 0.85
Ni(II) affects ubiquitination of core histones H2B and H2A. Exp Cell Res (2006) 0.84
Phagocytosis of nickel subsulfide particles during the early stages of neoplastic transformation in tissue culture. Cancer Res (1980) 0.84
Relative susceptibilities of C57BL/6, (C57BL/6 x C3H/He)F1, and C3H/He mice to acute toxicity and carcinogenicity of nickel subsulfide. Toxicology (1996) 0.84
Nickel absorption and kinetics in human volunteers. Proc Soc Exp Biol Med (1989) 0.83
Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of BigBlue rats and Muta Mouse mice in vivo after inhalation. Mutat Res (1998) 0.83
The role of nickel and nickel-mediated reactive oxygen species in the mechanism of nickel carcinogenesis. Environ Health Perspect (1994) 0.83
The metabolism of nickel-63 carbonyl. Toxicol Appl Pharmacol (1968) 0.83
Effects of calcium and magnesium salts on nickel subsulfide carcinogenicity in Fischer rats. Carcinogenesis (1985) 0.82
Selective phagocytosis of crystalline metal sulfide particles and DNA strand breaks as a mechanism for the induction of cellular transformation. Cancer Res (1982) 0.82
Compartmental analysis of the metabolism of 63Ni(II) in rats and rabbits. Res Commun Chem Pathol Pharmacol (1973) 0.82
An autoradiographic study on the distribution of 63NiCl2 in mice. Ann Clin Lab Sci (1979) 0.82
Crystalline Ni3S2 specifically enhances the formation of oxidants in the nuclei of CHO cells as detected by dichlorofluorescein. Carcinogenesis (1994) 0.82
Nickel binding to histone H4. Dalton Trans (2009) 0.81
Distinct mechanisms of oxidative DNA damage induced by carcinogenic nickel subsulfide and nickel oxides. Environ Health Perspect (2002) 0.81
Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol (2006) 4.71
Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics (2009) 1.96
Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res (2006) 1.78
Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol Cell Biol (2006) 1.77
Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem (2004) 1.66
Arsenite alters global histone H3 methylation. Carcinogenesis (2008) 1.53
The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol (2002) 1.48
Epigenetics and the environment. Ann N Y Acad Sci (2003) 1.47
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis (2007) 1.47
Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis (2006) 1.32
Phosphorylation of H3S10 blocks the access of H3K9 by specific antibodies and histone methyltransferase. Implication in regulating chromatin dynamics and epigenetic inheritance during mitosis. J Biol Chem (2008) 1.27
The potential protective effects of taurine on coronary heart disease. Atherosclerosis (2009) 1.27
Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions. Cancer Res (2008) 1.26
Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol (2009) 1.23
Global levels of histone modifications in peripheral blood mononuclear cells of subjects with exposure to nickel. Environ Health Perspect (2011) 1.20
DMT1: which metals does it transport? Biol Res (2006) 1.19
Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase. Cancer Res (2010) 1.18
JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70. Cancer Res (2010) 1.18
Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers. J Biol Chem (2009) 1.17
Soluble nickel inhibits HIF-prolyl-hydroxylases creating persistent hypoxic signaling in A549 cells. Mol Carcinog (2006) 1.17
Covalent modifications of histones during mitosis and meiosis. Cell Cycle (2009) 1.16
Histone modifications and cancer: biomarkers of prognosis? Am J Cancer Res (2012) 1.15
Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway. Carcinogenesis (2008) 1.14
Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells. Carcinogenesis (2010) 1.14
Nickel compounds act through phosphatidylinositol-3-kinase/Akt-dependent, p70(S6k)-independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal Cl41 cells. Cancer Res (2004) 1.13
Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics (2012) 1.12
Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium. Toxicol Appl Pharmacol (2009) 1.12
Soluble nickel interferes with cellular iron homeostasis. Mol Cell Biochem (2005) 1.11
Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C. Cancer Res (2002) 1.09
Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Toxicol Appl Pharmacol (2003) 1.08
The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals. Free Radic Biol Med (2012) 1.08
Nickel decreases cellular iron level and converts cytosolic aconitase to iron-regulatory protein 1 in A549 cells. Toxicol Appl Pharmacol (2004) 1.07
Carcinogenic effect of nickel compounds. Mol Cell Biochem (2005) 1.07
Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res (2007) 1.07
Iron- and 2-oxoglutarate-dependent dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicity. Biometals (2008) 1.04
PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J Cell Biol (2004) 1.03
Nickel compounds render anti-apoptotic effect to human bronchial epithelial Beas-2B cells by induction of cyclooxygenase-2 through an IKKbeta/p65-dependent and IKKalpha- and p50-independent pathway. J Biol Chem (2006) 1.03
Molecular responses to hypoxia-inducible factor 1α and beyond. Mol Pharmacol (2014) 1.03
Comparison of gene expression profiles in chromate transformed BEAS-2B cells. PLoS One (2011) 1.03
The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res (2003) 1.02
Nutritionally mediated oxidative stress and inflammation. Oxid Med Cell Longev (2013) 1.01
Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activity. Toxicol Appl Pharmacol (2007) 1.00
Mechanisms of c-myc degradation by nickel compounds and hypoxia. PLoS One (2009) 0.99
Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh. Cancer Epidemiol Biomarkers Prev (2012) 0.99
Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer. Metallomics (2012) 0.97
Essential role of ROS-mediated NFAT activation in TNF-alpha induction by crystalline silica exposure. Am J Physiol Lung Cell Mol Physiol (2006) 0.97
Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients. Clin Cancer Res (2004) 0.97
Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis. Crit Rev Toxicol (2013) 0.97
Effects of nickel treatment on H3K4 trimethylation and gene expression. PLoS One (2011) 0.96
Fluorescent tracking of nickel ions in human cultured cells. Toxicol Appl Pharmacol (2006) 0.96
Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1alpha. J Biol Chem (2010) 0.94
Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes. Toxicol Appl Pharmacol (2006) 0.93
A genome-wide screen in Saccharomyces cerevisiae reveals pathways affected by arsenic toxicity. Genomics (2009) 0.93
Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation. J Cell Physiol (2009) 0.92
Molecular mechanisms in nickel carcinogenesis: modeling Ni(II) binding site in histone H4. Environ Health Perspect (2002) 0.91
Heterochromatinization as a potential mechanism of nickel-induced carcinogenesis. Biochemistry (2009) 0.91
Hypoxia inducible factor-1 alpha-independent suppression of aryl hydrocarbon receptor-regulated genes by nickel. Mol Pharmacol (2003) 0.91
JNK1, but not JNK2, is required for COX-2 induction by nickel compounds. Carcinogenesis (2006) 0.91
Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis. Cancer Cell Int (2010) 0.91
Effect of soluble nickel on cellular energy metabolism in A549 cells. Exp Biol Med (Maywood) (2006) 0.90
Activation of nuclear factor-kappaB and not activator protein-1 in cellular response to nickel compounds. Environ Health Perspect (2002) 0.90
Differential role of hydrogen peroxide in UV-induced signal transduction. Mol Cell Biochem (2002) 0.90
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma. Invest New Drugs (2009) 0.89
Nickel compounds induce apoptosis in human bronchial epithelial Beas-2B cells by activation of c-Myc through ERK pathway. Toxicol Appl Pharmacol (2008) 0.89
The effect of exposure to carcinogenic metals on histone tail modifications and gene expression in human subjects. J Trace Elem Med Biol (2012) 0.89
Effect of metal ions on HIF-1alpha and Fe homeostasis in human A549 cells. Mutat Res (2006) 0.88
Sequence specificity of Cr(III)-DNA adduct formation in the p53 gene: NGG sequences are preferential adduct-forming sites. Carcinogenesis (2005) 0.88
Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice. Toxicol Appl Pharmacol (2004) 0.88
Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ Health Perspect (2002) 0.88
Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells. Carcinogenesis (2003) 0.87
Differential effects of polycyclic aromatic hydrocarbons on transactivation of AP-1 and NF-kappaB in mouse epidermal cl41 cells. Mol Carcinog (2004) 0.87
Dietary chromium and nickel enhance UV-carcinogenesis in skin of hairless mice. Toxicol Appl Pharmacol (2007) 0.87
Particulate matter from Saudi Arabia induces genes involved in inflammation, metabolic syndrome and atherosclerosis. J Toxicol Environ Health A (2014) 0.87
Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. Toxicol Appl Pharmacol (2003) 0.86
GeneChip analysis of signaling pathways effected by nickel. J Environ Monit (2003) 0.86
Alterations of histone modifications by cobalt compounds. Carcinogenesis (2009) 0.86
The role of hypoxia-inducible signaling pathway in nickel carcinogenesis. Environ Health Perspect (2002) 0.84
Nickel-induced down-regulation of serpin by hypoxic signaling. Toxicol Appl Pharmacol (2004) 0.84
Nickel-induced 1,4-alpha-glucan branching enzyme 1 up-regulation via the hypoxic signaling pathway. Toxicol Appl Pharmacol (2004) 0.84
Roles of MAPK pathway activation during cytokine induction in BEAS-2B cells exposed to fine World Trade Center (WTC) dust. J Immunotoxicol (2010) 0.83
X-ray absorption spectroscopy structural investigation of early intermediates in the mechanism of DNA repair by human ABH2. Biochemistry (2011) 0.83
Essential role of PI-3K, ERKs and calcium signal pathways in nickel-induced VEGF expression. Mol Cell Biochem (2005) 0.82
Gene expression profiles in peripheral blood mononuclear cells of Chinese nickel refinery workers with high exposures to nickel and control subjects. Cancer Epidemiol Biomarkers Prev (2012) 0.82
Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line. Int J Environ Res Public Health (2005) 0.82
Gene expression profiling and pathway analysis of human bronchial epithelial cells exposed to airborne particulate matter collected from Saudi Arabia. Toxicol Appl Pharmacol (2012) 0.82
Nickel binding to histone H4. Dalton Trans (2009) 0.81
A genome-wide deletion mutant screen identifies pathways affected by nickel sulfate in Saccharomyces cerevisiae. BMC Genomics (2009) 0.81
Liprin-α4 is required for nickel induced receptor protein tyrosine phosphatase-leukocyte antigen related receptor F (RPTP-LAR) activity. PLoS One (2011) 0.81
c-Myc mediates a hypoxia-induced decrease in acetylated histone H4. Biochimie (2009) 0.81
Chromatin immunoprecipitation assays. Methods Mol Biol (2004) 0.81
Sodium metavanadate exhibits carcinogenic tendencies in vitro in immortalized human bronchial epithelial cells. Metallomics (2013) 0.80
Altered iron homeostasis involvement in arsenite-mediated cell transformation. Free Radic Biol Med (2005) 0.80
ERKs activation and calcium signaling are both required for VEGF induction by vanadium in mouse epidermal Cl41 cells. Mol Cell Biochem (2005) 0.80
A Potential New Mechanism of Arsenic Carcinogenesis: Depletion of Stem-Loop Binding Protein and Increase in Polyadenylated Canonical Histone H3.1 mRNA. Biol Trace Elem Res (2015) 0.80
Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women. Br J Nutr (2010) 0.79
Comparison of the cytotoxicity, cellular uptake, and DNA-protein crosslinks induced by potassium chromate in lymphoblast cell lines derived from three different individuals. Biol Trace Elem Res (2002) 0.79
Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol (2011) 0.79
CrVI exposure and biomarkers: Cr in erythrocytes in relation to exposure and polymorphisms of genes encoding anion transport proteins. Biomarkers (2008) 0.78
Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of histone demethylases using X-ray absorption spectroscopy. Biochemistry (2013) 0.78
Serum taurine and risk of coronary heart disease: a prospective, nested case-control study. Eur J Nutr (2012) 0.78